Merck



Prescribing Information

SINGULAIR®
(MONTELUKAST SODIUM)
TABLETS, CHEWABLE TABLETS, AND ORAL GRANULES

View the Prescribing Information in PDF Format [English]

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For additional safety information, please see Patient Information.

This site is intended only for residents of the United States, its territories, and Puerto Rico.
SINGULAIR is a registered trademark of Merck & Co., Inc.
20850565(9)-08/09-SNG